Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
1,040.73
+0.73 (+0.07%)
Streaming Delayed Price
Updated: 3:23 PM EST, Feb 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,742,466
Open
1,045.61
Bid (Size)
1,040.53 (80)
Ask (Size)
1,041.02 (80)
Prev. Close
1,040.00
Today's Range
1,040.00 - 1,067.00
52wk Range
623.78 - 1,133.95
Shares Outstanding
956,580,893
Dividend Yield
0.58%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More
↗
Today 15:36 EST
Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing multiple clinical-stage programs.
Via
The Motley Fool
1 Reason I'd Buy Eli Lilly Stock and Never Sell
↗
Today 12:35 EST
A robust pipeline is essential for a buy-and-hold pharmaceutical stock.
Via
The Motley Fool
Topics
Intellectual Property
Performance
YTD
-3.7%
-3.7%
1 Month
-0.1%
-0.1%
3 Month
+1.9%
+1.9%
6 Month
+49.1%
+49.1%
1 Year
+21.4%
+21.4%
More News
Read More
The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot
Today 12:04 EST
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Eli Lilly & Co (NYSE:LLY) Combines Explosive Growth with a Bullish Technical Setup
↗
Today 4:01 EST
Via
Chartmill
NVO Stock Generates Retail Buzz After European Commission Approves 7.2 MG Once-Weekly Dose Of Wegovy Injection
↗
Today 11:22 EST
Via
Stocktwits
Topics
Lawsuit
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk
↗
Today 11:04 EST
Via
Investor's Business Daily
Topics
Lawsuit
2026 Could Be a Big Year for Viking Therapeutics. Time to Buy?
↗
Today 8:35 EST
Via
The Motley Fool
Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients
↗
Today 6:42 EST
Via
Benzinga
Nasdaq, S&P 500 Futures Lower As AI Disruption Fears Linger: Why AAPL, ZIM, OCUL, NCLH Are On Traders' Radar Today
↗
Today 3:31 EST
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
Economy
Novo Nordisk's New Diabetes Drug Outshines Ozempic: Is The Stock a Buy?
↗
February 16, 2026
Via
The Motley Fool
Liberty One Cuts Its Lamb Weston Position in Half With $32 Million Sale
↗
February 16, 2026
Via
The Motley Fool
Topics
Economy
Regulatory Compliance
Supply Chain
Forget AI Stocks: This Pharma Giant Is Using AI to Dominate Drug Discovery
↗
February 15, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
The Smartest Growth ETF to Buy With $1,000 Right Now. (Hint: It Has Averaged Annual Gains of 18.6% Over the Past 10 Years.)
↗
February 15, 2026
Via
The Motley Fool
Topics
ETFs
Eli Lilly Just Delivered Great News for Investors -- and It Goes Beyond Weight-Loss Drugs
↗
February 15, 2026
Via
The Motley Fool
What Is One of the Best Pharmaceutical Stocks to Own for the Next 10 Years?
↗
February 14, 2026
Via
The Motley Fool
Topics
Intellectual Property
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
↗
February 14, 2026
Via
The Motley Fool
Novo Nordisk To Meet Wegovy Pill Demand In US Before Expanding To Avoid Supply Shortage, Says CEO Doustdar
↗
February 13, 2026
Via
Stocktwits
Topics
Lawsuit
"Blowout" Jobs Report Ignites 2026 Growth Hopes as Unemployment Hits 4.3% Floor
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Workforce
Hospitals Stand Tall: Healthcare Sector Becomes Safe Haven Amid "Warsh Shock" and Tech Volatility
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?
↗
February 13, 2026
Via
The Motley Fool
The Great 2026 Divergence: Tech Titans Rise on AI Execution While Healthcare Reaps a Regulatory Whirlwind
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026
↗
February 13, 2026
Via
The Motley Fool
Topics
Intellectual Property
Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms
↗
February 13, 2026
Via
Benzinga
Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI Data: Why NVDA, AAPL, TSLA, RIVN, MRNA, AMAT, IREN Are On Traders' Radar Today
↗
February 13, 2026
Via
Stocktwits
Topics
Bonds
ETFs
Economy
Meta Platforms Breaks Ground on Massive $10 Billion Indiana Data Center: A Giant Leap Toward 'Personal Superintelligence'
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,040.73
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 02/17/26 03:23 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 995.54B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 996B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.